The 57Co excretion and resorption test in the diagnosis of iron deficiency anemia
Creators
- 1. Kantonsspital Sankt Gallen (Switzerland). Medizinische Klinik C
- 2. Kantonsspital Sankt Gallen (Switzerland). Inst. fuer Medizinische Radiologie und Nuklearmedizin
Description
1971 Sorbie et al. described a simple 57Co-excretion test (16) as an aid in the diagnosis of iron deficiency anemia. The authors found that renal excretion of a tracer dosis of 0,5 μCi 57CoCl2 was significantly elevated in patients with iron deficiency anemia (31% of the adminstered dose in 24 hours' urine) as compared with the controls (18%). Between 1972-1974 we performed the 57Co-excretion test in 29 patients with different kind of anemia and in 10 healthy volunteers. The test was modified by measurement of the serum activity 1, 2, 3, 7, 11 and 24 hours after the oral administration of the test dosis. In all anemias as well as in the control group we found the maximum of serum activity three hours after the oral administration of the tracer. The three hours serum activity was elevated in patients with iron deficiency anemia (5.53%/l serum) as compared with the control group (1.92%/l) and renal, tumor and infectious anemia (1.20%/l) p < 0.01. The 57Co excretion was moderately elevated in most of the patients with iron deficiency anemia (average 31.5% 57Co-activity in 24 hours' urine) in comparison to the healthy controls (average 25.30%). Contrary to the results obtained by Sorbie et al. we found a wide range of fluctuation of the Co-excretion test in each group of patients with a poor statistical significance of p > 0.05. (orig.)
Abstract (German)
Im Jahre 1971 beschrieben Sorbie und Mitarbeiter (16) den 57Co-Exkretionstest als eine einfache und zuverlässige Methode in der Diagnose der Eisenmangelanämie. Nach oraler Applikation von 0,5 μCi 57Co (20 μmol CoCl2) fanden die Autoren eine renale Ausscheidung der Testdosis von 31% im 24-Stunden-Urin bei Eisenmangelanämien gegenüber 18% bei gesunden Kontrollpersonen. In den Jahren 1972—1974 führten wir diesen Test bei 29 Patientinnen und Patienten mit verschiedenen Anämien sowie bei 10 gesunden Kontrollpersonen durch. Neben der renalen Ausscheidung von 57Cobalt haben wir zusätzlich die Serumaktivität 1, 2, 3, 7, 11 und 24 Stunden nach der Applikation der Testdosis gemessen. Sowohl bei den gesunden Kontrollpersonen als auch bei allen Anämieformen fanden wir das Aktivitätsmaximum im Serum 3 Stunden p.c., danach nahm die Aktivität langsam ab. Die 3-Stunden-Serumaktivität (57Co-Resorptionstest) war bei den Patienten mit einer Eisenmangelanämie mit durchschnittlich 5,53 %/L Serum gegenüber der Kontrollgruppe (1,92 %/L) signifikant erhöht (p 0,05 schlecht.Additional details
Additional titles
- Original title (German)
- Der
Identifiers
Publishing Information
- Journal Title
- Nuklearmedizin
- Journal Volume
- 15
- Journal Issue
- 03
- Series
- Nucl.-Med.
- Journal Page Range
- 126-130
- ISSN
- 0029-5566
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 7270735
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANEMIAS; BLOOD-PLASMA CLEARANCE; COBALT CHLORIDES; COBALT 57; DIAGNOSIS; DIAGNOSTIC TECHNIQUES; EXCRETION; HEMOGLOBIN; IRON COMPLEXES; NUCLEAR MEDICINE; PATIENTS; RADIONUCLIDE KINETICS; RETENTION
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; CARBOXYLIC ACIDS; CHLORIDES; CHLORINE COMPOUNDS; CLEARANCE; COBALT COMPOUNDS; COBALT ISOTOPES; COMPLEXES; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; GLOBIN; HALIDES; HALOGEN COMPOUNDS; HEMIC DISEASES; HETEROCYCLIC ACIDS; HETEROCYCLIC COMPOUNDS; INTERMEDIATE MASS NUCLEI; ISOTOPES; KINETICS; MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; PIGMENTS; PORPHYRINS; PROTEINS; RADIOISOTOPES; SYMPTOMS; TRANSITION ELEMENT COMPLEXES; TRANSITION ELEMENT COMPOUNDS
Optional Information
- Notes
- 5 figs.; 1 tab.; 19 refs.; Updated automatically by Metadata and Full-Text Enrichment Agent